Postday One-step Tablet
Product Images NDC 69953-628

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 1 technical images submitted to the FDA as part of the official labeling for Postday One-step (NDC 69953-628). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rapha Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Label (Fda Submission Artwork)

Label (Fda Submission Artwork)
This is a description of the emergency contraceptive pill PostDay One-Step that contains Levonorgestrel 1.5mg. It can be taken to reduce the chances of pregnancy after unprotected sex. A user can take one tablet as soon as possible, but no longer than 72 hours or three days afterward. It cannot be used as regular birth control and is not effective against sexually transmitted diseases. Possible side effects and instructions are included in the package.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.